Anti-PD1 and anti-PD-L1 in the treatment of metastatic melanoma
{{output}}
Programmed cell death receptor-1 (PD-1) and programmed cell death-1 ligand-1 (PD-L1) represent promising novel targets in immunotherapy. PD-1 is an inhibitory receptor involved in T-cell regulation that is expressed by activated T cells. Nivolumab and pembroli... ...
